Related by context. All words. (Click for frequent words.) 72 serum phosphorus 71 plasma concentrations 71 μmol L 70 serum concentrations 70 nmol liter 70 mcg mL 70 lumbar spine BMD 70 AUC0 69 rizatriptan 69 aspartate aminotransferase 69 lispro 69 alanine aminotransferase 68 #mg dose [001] 68 #.#mg/dL 68 serum urate 68 mg dose 68 NPH insulin 67 nM 67 abacavir lamivudine 67 serum phosphate levels 67 μg 67 uM 67 HbA 1c 67 #μg [002] 67 HBeAg seroconversion 67 μg kg 67 #mg/day [002] 67 pg ml 67 mcg BID 67 pg mL 67 #ug [001] 67 mg TID 67 gastric pH 67 serum potassium 66 8mg 66 concentration Cmax 66 glucuronide 66 log# copies mL 66 #mg BID [003] 66 bronchodilation 66 CrCl 66 #.#/#.# mm Hg [003] 66 peak plasma concentrations 66 #μg [001] 66 4mg/kg 66 insulin detemir 66 SCr 65 mmol L 65 sUA 65 creatinine ratio 65 systemic bioavailability 65 mmol l 65 transaminases 65 μg mL 65 intramuscularly 65 #mg/kg [002] 65 creatinine clearance 65 hemoglobin Hb 65 μg L 65 mg kg dose 65 g dl 65 serum testosterone 65 ug kg 65 leukocyte count 65 serum ALT 65 mg d 65 neutrophil counts 65 mg qd 65 pmol L 65 CK MB 65 -#.# mg dL [002] 65 normal ULN 65 hours postdose 65 lopinavir r 65 mcg dose 65 coadministration 65 antibody titer 65 blood Phe 65 μg ml 65 Plasma concentrations 65 serum cortisol 65 mL/min/#.# m 2 65 mg QD 65 #mg/day [001] 65 alanine aminotransferase ALT 65 baseline HbA1c 65 aspartate aminotransferase AST 65 HOMA IR 65 urinary N telopeptide 64 plasma glucose 64 LEXIVA r 64 Tmax 64 apolipoprotein B 64 plasma glucose levels 64 mL kg 64 μg d 64 #mg/dL [002] 64 #.#mmol L [002] 64 biphasic insulin aspart 64 mcg kg 64 lactate dehydrogenase LDH 64 plasma leptin 64 achieved statistical significance 64 8mg/kg 64 intact parathyroid hormone 64 triglycerides TG 64 budesonide pMDI 64 amprenavir 64 NOAEL 64 chlorambucil 64 #.#/#.# mmHg [001] 64 microg 64 mcg ml 64 serum phosphate 64 oxycodone CR 64 corrected QT interval 64 #mg dose [003] 64 ng dL 64 aPTT 64 fasting plasma glucose FPG 64 pharmacokinetic parameters 64 Hb A1C 64 nicardipine 64 progression TTP 64 mEq L 64 eosinophil count 64 PaO 2 64 3mg 64 zonisamide SR 64 transdermal estradiol 63 mg/m2 dose 63 fluvastatin 63 CK # plasma concentrations 63 systolic diastolic blood 63 nmol 63 #mg doses [002] 63 MIC# [001] 63 6mg 63 mg doses 63 desvenlafaxine succinate 63 hemoglobin A1c HbA1c 63 BENICAR HCT 63 postprandial glucose 63 #mg #mg [001] 63 nmol L 63 prolactin levels 63 serum leptin 63 aminotransferases 63 AUCs 63 serum LDL cholesterol 63 serum aminotransferase levels 63 mIU ml 63 detemir 63 % Confidence Interval 63 #ug [002] 63 μg dose 63 SGPT 63 fructosamine 63 plasma uric acid 63 posaconazole 63 pharmacokinetic profile 63 REYATAZ r arm 63 ULORIC 63 hemoglobin concentrations 63 statin monotherapy 63 fraction LVEF 63 placebo p = 63 piperacillin tazobactam 63 AST ALT 63 glycated hemoglobin levels 63 systolic BP 63 virologic failure 63 mg simvastatin 63 serum urate levels 63 rabeprazole 63 Acetate Rectal Suppositories 63 serum calcium 63 lanthanum carbonate 63 octreotide LAR 63 subcutaneously administered 63 PRADAXA #mg 63 serum triglycerides 63 certolizumab 63 MADRS score 63 mm Hg systolic 63 elevated creatinine 63 HbA1C levels 63 plasma renin activity 63 mcg QD 63 #mg dose [002] 63 urinary excretion 63 5-FU/LV 63 #mg/m# [002] 63 tirofiban 63 mg tid 63 urinary albumin excretion 63 alanine transaminase 63 CR nPR 63 placebo p 63 serum sodium 63 subcutaneous dose 63 ug ml 63 #.#mg/kg [002] 62 serum uric acid 62 mmol 62 APTIVUS r 62 cells uL 62 mg/m2/day 62 intravenous bolus 62 irbesartan 62 plasma concentration Cmax 62 serum HBV DNA 62 CIMZIA TM 62 saline placebo 62 interferon alfa 62 GHRH 62 log# 62 #mg/m# [001] 62 maximally tolerated dose 62 serum phosphorous 62 virologic response 62 HIV RNA 62 selective modulator 62 achieved ACR# 62 dose dependently 62 administered subcutaneously 62 tipranavir r 62 serum CRP 62 diastolic BP 62 plasma triglycerides 62 atazanavir ritonavir 62 ml kg 62 clinically meaningful improvement 62 elevated ALT 62 P = .# 62 atorvastatin #mg 62 nanomolar 62 lopinavir r arm 62 tamsulosin 62 hemoglobin concentration 62 mIU mL 62 serum calcium levels 62 q#h 62 flutamide 62 mg BID 62 Fasting plasma glucose 62 PASI scores 62 serum albumin 62 #.#mg [003] 62 DLTs 62 kilogram mg kg 62 AUC0 #hr 62 DAS# remission 62 zoledronate 62 sUA levels 62 plasma folate 62 #ng/ml 62 maximal dose 62 glycosylated hemoglobin HbA1c 62 dosing frequency 62 fluticasone furoate 62 binary restenosis 62 serum magnesium 62 #.#mg [004] 62 plasma pharmacokinetics 62 antibody titers 62 hsCRP levels 62 fosamprenavir 62 ng mL 62 glomerular filtration 62 serum IGF 62 mean baseline HbA1c 62 unfractionated heparin 61 fasting triglycerides 61 comparator arm 61 lumbar spine bone 61 ritonavir boosted 61 dalteparin 61 β blockers 61 paricalcitol 61 μg liter 61 dehydroepiandrosterone sulfate 61 ziprasidone 61 iPTH 61 mg ustekinumab 61 LPV r 61 noninferiority 61 mg m² 61 maximal tolerated 61 pretreatment baseline 61 azacitidine 61 isoproterenol 61 IFN α 61 isoprostane 61 tapentadol ER 61 #.#g/day 61 #mmHg [001] 61 racemic albuterol 61 plasma HCV RNA 61 fluticasone salmeterol 61 nadolol 61 undetectable viral 61 statistical significance p 61 hematological parameters 61 ug mL 61 serum creatinine levels 61 #/#mg 61 interferon alfa 2b 61 ALT elevations 61 LANTUS R 61 adjunctive placebo 61 neutrophil count 61 insulin lispro 61 undetectable HBV DNA 61 ALVESCO 61 timepoints 61 urinary oxalate 61 Serum creatinine 61 sodium nitroprusside 61 MBq 61 trandolapril 61 plus medroxyprogesterone acetate 61 estramustine 61 per deciliter mg 61 intravenous dosing 61 dapagliflozin plus 61 indinavir 61 ng dl 61 seroprotection 61 mU 61 mmHg diastolic 61 OGTT 61 rHuPH# 61 systemic absorption 61 balsalazide 61 diuretic chlorthalidone 61 HbA 1c levels 61 ertapenem 61 QTc 61 fasting plasma 61 plasma urate 61 titers 61 dose cohort 61 urinary albumin 61 protein excretion 61 glycemia 61 mean serum phosphorus 61 pharmacodynamic PD 61 BENICAR 61 oxycodone IR 61 QTcF 61 euthyroid 61 serum PTH 61 g dL 61 salmeterol fluticasone 61 lactate dehydrogenase 61 periprocedural 61 HCV replicon 61 hydroxymethyl coenzyme 61 isoenzyme 61 kg -1 61 lispro alone 61 log# reduction 61 caspofungin 61 valsartan 61 antiandrogen 61 unfractionated heparin UFH 61 ribavirin USP 61 pharmacokinetics PK 61 IU ml 61 IIIa inhibitor 61 QD dosing 61 -#.# ± [002] 61 = #.#-#.# 61 plasma cortisol 61 #mg [003] 61 mg kg 61 sodium excretion 60 LEXIVA 60 pCR 60 #mg QD [002] 60 subcutaneously injected 60 hMG 60 #mg/kg [001] 60 nondiabetic patients 60 QTc intervals 60 HER2 expression 60 IV DHE 60 insulin glargine 60 pulmonary exacerbations 60 glycated hemoglobin HbA1c 60 HbA1c levels 60 mU liter 60 clodronate 60 lumiracoxib 60 mL sec 60 #OHD 60 acetazolamide 60 transaminase elevations 60 CR CRu 60 steroid dexamethasone 60 fluticasone propionate FP 60 Hb 60 CD4 + cell 60 systemically administered 60 pyrazinamide 60 -#.# log# copies mL 60 3mg/kg 60 OADs 60 IELT 60 ramipril 60 min -1 60 liver histology 60 Peg IFN 60 hypogonadal 60 glomerular filtration rate 60 pmol 60 6MWD 60 Flu Cy 60 bioavailable testosterone 60 micromolar 60 symptomatic intracranial hemorrhage 60 dosage regimens 60 tinzaparin 60 2mg 60 + PH# 60 PEG IFN 60 oral prednisone 60 subcutaneous insulin 60 epoetin alpha 60 antiviral efficacy 60 mmHg systolic 60 CCyR 60 SVR# 60 eplerenone 60 lowest tertile 60 Mg Uk 60 analgesic efficacy 60 platelet aggregation 60 Omacetaxine mepesuccinate 60 severe neutropenia 60 divalproex sodium 60 nephrotoxicity 60 hyperphenylalaninemia HPA due 60 nmol l 60 liver transaminases 60 neurologic progression 60 tHcy 60 Ophena TM 60 umol L 60 intima media thickness 60 #.#mmol L [001] 60 serum retinol 60 pharmacokinetic characteristics 60 mmHg 60 urinary calcium 60 1mg 2mg 60 mg 60 tolterodine 60 pharmacokinetic PK profile 60 lymphocyte counts 60 dose proportionality 60 prespecified 60 tertiles 60 aminotransferase levels 60 Pharmacokinetic parameters 60 bezafibrate 60 calculated creatinine clearance 60 -#.# mg dL [001] 60 HBV DNA levels 60 test OGTT 60 lymphocyte count 60 creatine kinase 60 cholesterol LDL C 60 #.#mmHg 60 Navelbine 60 mg/# hours 60 mcg 60 fluorouracil leucovorin 60 Engerix B 60 rhEPO 60 epoetin alfa 60 paraprotein 60 IgG antibody 60 quetiapine 60 undetectable HCV RNA 60 potent CYP#A# inhibitors 60 d amphetamine 60 mCi kg 60 mg RDEA# 60 β blocker 60 thromboembolic events 60 maximal doses 60 biochemical relapse 60 infarct size 60 timolol 60 ng ml 60 Linagliptin 60 #mg #mg #mg [003] 60 PSA nadir 60 serum cholesterol 60 mmol kg 60 bolus injection 60 x ULN 60 atheroma volume 60 circulating IGF 60 mg orally 60 FFNS 59 limiting toxicity 59 gemcitabine cisplatin 59 #mg/dL [001] 59 transaminase 59 IU mL 59 FOSRENOL ® 59 mesalamine granules 59 p = .# [002] 59 recurrent VTE 59 hematologic toxicity 59 highly emetogenic 59 triglyceride TG 59 budesonide formoterol 59 rFSH 59 partial thromboplastin 59 postprandial glycemia 59 baseline FEV 59 mCi 59 pharmacodynamic effects 59 gliclazide 59 Danazol 59 cytopenias 59 receptor blockers 59 active metabolite 59 glulisine 59 pentoxifylline 59 endometrial thickness 59 miconazole 59 fasting glucose levels 59 cTnI 59 mcg doses 59 splenectomized patients 59 q8h 59 ABC/3TC 59 postprandial blood glucose 59 antiretroviral naive 59 noninferior 59 CANCIDAS 59 GH secretion 59 thyrotropin 59 abciximab 59 RLAI 59 complete cytogenetic response 59 tolvaptan 59 intranasally administered 59 oral rivaroxaban 59 nitroprusside 59 pharmacodynamics PD 59 pulmonary artery pressure 59 postdose 59 triacylglycerol concentrations 59 serum phosphorus levels 59 IFN alpha 59 #mmHg [002] 59 troponin T 59 cefazolin 59 μM 59 delivered subcutaneously 59 platelet inhibition 59 triglyceride concentrations 59 AUA Symptom Score 59 db db mice 59 fractional shortening 59 p = NS 59 hypomagnesemia 59 serum testosterone levels 59 blood Phe levels 59 pharmacokinetic interactions 59 glucocorticoid 59 bosentan 59 dosed orally 59 peginterferon alfa 2b 59 Lantus ® 59 triacylglycerol 59 Hb levels 59 intravenously administered 59 olmesartan 59 activated partial thromboplastin 59 HBeAg positive 59 MULTAQ 59 coadministered 59 ketorolac 59 nelfinavir 59 mU L 59 arbaclofen 59 osmolality 59 serum creatinine 59 anemia hemoglobin 59 lipoprotein Lp 59 urate lowering therapy 59 Elitek 59 nanomolar range 59 GLP1 59 Sumatriptan OS 59 A1c levels 59 edoxaban 59 active comparator 59 mg XP# 59 Pharmacokinetic 59 mm3 59 baseline Hb 59 Aclidinium 59 -#.# ± [001] 59 rapid virologic response 59 alteplase 59 HBV DNA 59 1mg dose 59 CC genotype 59 QT QTc 59 mIU L 59 Pharmacokinetic studies 59 Lupuzor ™ 59 peginterferon alfa 2a 59 reactogenicity 59 benazepril 59 Febrile neutropenia 59 deoxy 59 Primary endpoints 59 mm Hg diastolic 59 mu g 59 IOP lowering 59 mRNA expression 59 tryptase 59 metoprolol tartrate 59 tizanidine 59 aripiprazole 59 Secondary endpoints include 59 baseline serum creatinine 59 paroxetine sertraline 59 glargine 59 Crohn Disease Activity 59 LATUDA 59 mg dl 59 acute gout flares 59 dacarbazine 59 dosing cohort 59 azilsartan medoxomil 59 injected subcutaneously 59 fondaparinux 59 rimonabant #mg 59 PREZISTA r 59 timepoint 59 idraparinux 59 detectable HCV RNA 59 oral allopurinol 59 serum insulin 59 zolmitriptan 59 Double Blind Randomized 59 plus prednisone prednisolone 59 confidence intervals CIs 59 #.#ng/ml 59 morphometric vertebral fractures 59 foveal thickness 59 Non inferiority 59 Apidra ® 59 pegIFN 59 pravastatin 59 inhibitory concentration 59 SHBG 59 LVEF 59 #mg/dl 59 inhaled fluticasone 59 CDAI score 59 transaminase levels 59 SGOT 59 pharmacodynamic 59 Creatinine 59 ibandronate 59 CI -#.# 59 COZAAR 59 candesartan cilexetil 59 oral antidiabetic medication 59 albumin excretion 59 blood phenylalanine Phe 59 PEGylated anti 59 moderate renal impairment 59 EDARBI 58 daunorubicin 58 CorVue ™ 58 TLUS 58 #.#mL 58 ALT AST 58 oblimersen 58 alfuzosin 58 plus COPEGUS 58 rHuEPO 58 mg dosed twice 58 IGFBP 3 58 glycosylated hemoglobin 58 chloride secretion 58 BARACLUDE ® 58 neostigmine 58 HBeAg negative patients 58 IFN beta 58 ascending doses 58 μg dL 58 Secondary endpoints included 58 platelet reactivity 58 S/GSK# 58 mmol L. 58 HCV RNA 58 endogenous EPO 58 9mg 58 dose colchicine 58 bolus dose 58 #mg [002] 58 serum estradiol 58 detrusor 58 R rifaximin tablets 58 ìg 58 ROZEREM TM 58 locomotor activity 58 culture supernatants 58 ritonavir boosted atazanavir 58 urate lowering 58 oxyhemoglobin 58 highest tertile 58 granisetron 58 subcutaneous SC 58 oxcarbazepine 58 nmol L. 58 insulin glulisine 58 mg dL 58 micromoles 58 placebo PBO 58 baseline A1C 58 attain statistical significance 58 tolterodine ER 58 beclomethasone dipropionate 58 IRLS score 58 VELCADE melphalan 58 symptomatic VTE 58 teriflunomide 58 interleukin IL -6 58 5 HT2C receptor 58 glycated hemoglobin 58 VIRAMUNE 58 Darusentan 58 serum lipid 58 secondary efficacy endpoint 58 mg eq 58 tertile 58 serum TSH 58 beta2 agonist 58 anti HBs 58 latanoprost 58 ml min 58 Pred Forte 58 5 Fluorouracil 58 severe renal impairment 58 ß carotene 58 HMG CoA reductase inhibitors 58 plus prednisone 58 pharmacologically active isomer 58 IIIa inhibitors 58 GnRH agonist 58 prospectively defined 58 mg kg bw 58 Prograf ® 58 statistically significant p = 58 mL/min/#.# m2 58 tapentadol IR 58 sitaxsentan 58 bone resorption 58 remifentanil 58 iodixanol 58 cEVR 58 femoral neck BMD 58 definite stent thrombosis 58 systemic embolism 58 lactulose 58 autoantibody levels 58 iloprost 58 urine albumin 58 subcutaneous enoxaparin 58 fasting insulin 58 0mg 58 XP# Transported Prodrug 58 weekly subcutaneous injections 58 #mg BID [001] 58 antipsychotic efficacy 58 serum glucose 58 serum ferritin 58 cholestyramine 58 ACR# responses 58 mEq 58 prednisone prednisolone 58 FEV1 58 adalimumab 58 normotensive 58 creatinine levels 58 proteinuria 58 -#.# log# 58 PREZISTA ritonavir 58 pulmonary arterial 58 -#.# mmol L 58 1mg 58 HDRS 58 apoA 58 malignancy HCM 58 baseline CD4 58 continuous intravenous infusion 58 febuxostat 58 efavirenz EFV 58 NovoLog ® Mix 58 equimolar 58 seroconversion 58 antiplatelet agent 58 laropiprant 58 guanfacine 58 acitretin 58 salmeterol fluticasone propionate 58 -5 -6 58 maintaining Hb 58 primary hypercholesterolemia 58 aminotransferase ALT 58 sinus tachycardia 58 TNFalpha 58 adiponectin concentrations 58 ketoconazole 58 Pioglitazone 58 selective agonist 58 homozygotes 58 somatostatin analog 58 leukocyte counts 58 ARB telmisartan 58 serum PSA 58 Hcy 58 tolerated dose MTD 58 Capecitabine 58 dopamine partial agonist 58 mg mL 58 oral diclofenac 58 fasting plasma glucose 58 treprostinil 58 plus dexamethasone 58 doxazosin 58 glimepiride 58 reticulocytes 58 pharmacokinetic profiles 58 budesonide 58 UACR 58 metformin monotherapy 58 serum homocysteine 58 insulin degludec 58 Eligen R B# 58 allopurinol 58 urocortin 2 58 TMC# r 58 FOLFIRI 58 verapamil 58 discontinuations due 58 receptor blocker 58 CsA 58 PROMACTA 58 MMSE score 58 AZT zidovudine Retrovir 58 methacholine challenge 58 dexmedetomidine 58 emtricitabine tenofovir 58 tacrolimus 58 LAB GHRH 58 ULN 58 metabolic parameters 58 Viral load 58 oxymorphone IR 58 hypogonadal men 58 ± SD 58 inflammatory lesions 58 carotid IMT 58 octreotide acetate 58 DCCR 58 statistically significant reduction 58 postintervention 58 ursodeoxycholic acid 58 doxorubicin docetaxel 58 atherogenic 58 oral antidiabetes 58 #.#mg 1mg 58 IPSS 58 plasma lipids 58 voriconazole 58 aliskiren 58 triacylglycerols 58 QTc interval 58 aprepitant 58 NATRECOR ® 58 haematological toxicity 58 clomipramine 58 oocytes retrieved 58 doxorubicin cyclophosphamide 58 LV ejection fraction 58 μg g 57 immunoreactivity 57 methylmalonic acid 57 plasma lipid 57 MAS XR 57 levetiracetam 57 Pemetrexed 57 vasopressor 57 pharmacokinetics 57 cells μL 57 pulmonary capillary wedge 57 recurrent venous thromboembolism 57 undetectable viral load 57 racemic 57 confidence interval CI 57 Solid Tumors criteria 57 symptomatic hypotension 57 ATACAND 57 cis retinoic acid 57 mmol liter 57 dose cytarabine 57 anagrelide 57 QTc prolongation 57 oxybutynin 57 statistically significant p 57 inhaled iloprost 57 dexamethasone Decadron 57 formoterol fumarate 57 darbepoetin alfa 57 fasting triglyceride levels 57 MIRCERA 57 nocturnal hypoglycaemia 57 low dose cytarabine 57 ARCOXIA 57 HCTZ 57 epoetin beta 57 deferoxamine 57 plasma fibrinogen 57 viral titers 57 HES CEL 57 TNF Tumor Necrosis Factor 57 linoleic acid LA 57 Sustained virologic response 57 mg kg IV 57 VAPRISOL 57 R# #mg BID 57 Psoriasis Area 57 PSADT 57 pharmacodynamics 57 mean corpuscular volume 57 placebo 57 oral bioavailability 57 prednisone prednisolone plus 57 decitabine 57 goserelin 57 mol L 57 systemic hypotension 57 Tekamlo 57 terfenadine 57 vasodilatory 57 microgram kg 57 bupropion SR 57 Posaconazole 57 TIMP 1 57 acromegalic patients 57 IFN alfa 57 ALT elevation 57 urinary cortisol 57 glycosylated hemoglobin levels 57 intracellular uptake 57 relapsed MM 57 quetiapine XR 57 daily subcutaneous injections 57 chlorthalidone 57 postprandial insulin 57 clinically meaningful reductions 57 mesalamine 57 circulating lymphocytes 57 PANSS scores 57 microsomal 57 ACh 57 alkaline phosphatase 57 adrenocorticotropic hormone 57 administered intramuscularly 57 IGFBP 57 Forodesine HCl 57 nitrotyrosine 57 heterozygotes 57 otamixaban 57 SHBG levels 57 pharmacodynamic profile 57 dose limiting toxicities 57 ropivacaine 57 interleukin IL -# 57 homocysteine concentrations 57 mg kg BID 57 hypokalemia 57 ApoB 57 HMG CoA reductase inhibitor